JANX vs NTLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
JANX Captures Institutional Edge (2โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Janux Therapeutics, Inc. Common Stock (JANX) driven by superior Growth & Margin, Options & Structure while NTLA counters with relative strength in Momentum & Technical. Fundamentally, JANX trades at N/M Forward P/E with -599.3% operating margin (-7.1% YoY revenue) versus NTLA at N/M Forward P/E and -826.0% operating margin (-48.0% YoY). In options structure, JANX sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | JANX Revenue | NTLA Revenue | JANX Op. Margin | NTLA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $30M | N/A | -298.6% | NTLA |
| FY2019 | N/A | $40M | N/A | -246.8% | NTLA |
| FY2020 | N/A | $60M | N/A | -235.5% | NTLA |
| FY2021 | $0M | $30M | -905.4% | -810.4% | NTLA |
| FY2022 | $10M | $50M | -779.0% | -879.0% | JANX |
| FY2023 | $10M | $40M | -902.9% | -1420.5% | JANX |
| FY2024 | $10M | $60M | -933.6% | -923.1% | NTLA |
| FY2025 | $10M | $70M | -1576.7% | -651.7% | NTLA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | JANX | NTLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $703.3M | $1.5B | Larger Scale | NTLA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -7.1% | -48.0% | Higher Growth | JANX |
| Operating Margin (TTM) Profitability | -599.3% | -826.0% | Higher Margin | JANX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -10.6% | -62.6% | Higher ROE | JANX |
| 52-Week Range Position Momentum | 1% ($11โ$35) | 20% ($8โ$18) | Stronger Trend | NTLA |
| Beta / 30D Volatility Risk Regime | 0.74ฮฒ ยท 118% Vol | 2.30ฮฒ ยท 87% Vol | Lower Realized Risk | NTLA |
| Unified Institutional Score Composite Signal | 45.0 / 100 (HOLD) | 50.7 / 100 (HOLD) | Higher Composite | NTLA |